Mutations in insulin-like growth factor receptor 1 gene (IGF1R) resulting in intrauterine and postnatal growth retardation;mutações no gene do receptor do fator de crescimento insulina-Símile 1 (IGF1R) como causa de retardo do crescimento pré- e pós-natal

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 8, 2011, Pages 541-549

  de Castro Leal, Andréa ^a   Canton, Ana Pinheiro Machado ^a   Montenegro, Luciana Ribeiro ^a   Coutinho, Débora Cabral ^a   Arnhold, Ivo Jorge Prado ^a   de Lima Jorge, Alexander Augusto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fetal growth retardation; Growth disorders; IGF type 1; Insulin like growth factor I; Mutation; Receptor

Indexed keywords

SOMATOMEDIN C RECEPTOR;

GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRAUTERINE GROWTH RETARDATION; MUTATION; NEWBORN; REVIEW; SMALL FOR DATE INFANT;

FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MUTATION; RECEPTOR, IGF TYPE 1;

EID: 84855430101     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000800007     Document Type: Review

References (41)

1. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, DenHartog H, De MuinckKeizer-Schrama SM, Drop SL. Children born small for gestational age: do they catch up? Pediatr Res. 1995;38(2):267-71.
2. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111(6 Pt 1):1253-61.
3. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007;92(3):804-10.
4. Saenger P, Czernichow P, Hughes I, Reiter EO. Small for ges-tational age: short stature and beyond. Endocrine reviews. 2007;28(2):219-51.
5. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intraute-rine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996;335(18):1363-7.
6. Gluckman PD. Clinical review 68: the endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab. 1995;80(4):1047-50.
7. Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) def-ciency. J Med Genet. 2003;40(12):913-7.
8. Coutinho DC, Coletta RR, Costa EM, Pachi PR, Boguszewski MC, Damiani D, et al. Polymorphisms identifed in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre- and postnatal growth impairment. J Clin Endocrinol Metab. 2007;92(12):4889-92.
9. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endo-crinol Metab. 2005;90(5):2855-64.
10. Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort JM, et al. Partial primary defciency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab. 2009;94(10):3913-21.
11. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lau-tier C, Keller E, et al. IGF-I receptor mutations resulting in in-trauterine and postnatal growth retardation. N Engl J Med. 2003;349(23):2211-22.
12. Ester WA, van Duyvenvoorde HA, de Wit CC, Broekman AJ, Rui-venkamp CA, Govaerts LC, et al. Two short children born small for gestational age with insulin-like growth factor 1 receptor haploin-suffciency illustrate the heterogeneity of its phenotype. J Clin Endocrinol Metab. 2009;94(12):4717-27.
13. Inagaki K, Tiulpakov A, Rubtsov P, Sverdlova P, Peterkova V, Yakar S, et al. A familial insulin-like growth factor-I receptor mutant leads to short stature: clinical and biochemical characterization. J Clin Endocrinol Metab. 2007;92(4):1542-8.
14. Kawashima Y, Kanzaki S, Yang F, Kinoshita T, Hanaki K, Nagaishi J, et al. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab. 2005;90(8):4679-87.
15. Raile K, Klammt J, Schneider A, Keller A, Laue S, Smith R, et al. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab. 2006;91(6):2264-71.
16. Walenkamp MJ, van der Kamp HJ, Pereira AM, Kant SG, van Duyvenvoorde HA, Kruithof M F, et al. A variable degree of intrau-terine and postnatal growth retardation in a family with a mis-sense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab. 2006;91(8):3062-70.
17. Kruis T, Klammt J, Galli-Tsinopoulou A, Wallborn T, Schlicke M, Muller E, et al. Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intraute-rine and postnatal growth retardation. J Clin Endocrinol Metab. 2010;95(3):1137-42.
18. Wallborn T, Wuller S, Klammt J, Kruis T, Kratzsch J, Schmidt G, et al. A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplas-mic reticulum and results in intrauterine and postnatal growth retardation. J Clin Endocrinol Metab. 2010;95(5):2316-24.
19. Ward CW, Garrett T P, McKern NM, Lou M, Cosgrove LJ, Sparrow LG, et al. The three dimensional structure of the type I insulin-like growth factor receptor. Mol Pathol. 2001;54(3):125-32.
20. Adams TE, Epa VC, Garrett T P, Ward CW. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci. 2000;57(7):1050-93.
21. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Rev. 2001;22(6):818-35.
22. Jain S, Golde DW, Bailey R, Geffner ME. Insulin-like growth fac-tor-I resistance. Endocrine Rev. 1998;19(5):625-46.
23. Dupont J. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. J Horm Res. 2001;55:22-6.
24. Liu J P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75(1):59-72.
25. Butler AA, LeRoith D. Minireview: tissue-specifc versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology. 2001;142(5):1685-8.
26. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet. 1996;12(1):106-9.
27. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-defciency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345(6270):78-80.
28. Duvillie B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, Mon-thioux E, et al. Phenotypic alterations in insulin-defcient mutant mice. Proc Natl Acad Sci U S A. 1997 13;94(10):5137-40.
29. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. Embo J. 1996;15(7):1542-7.
30. Ueki K, Yamauchi T, Tamemoto H, Tobe K, Yamamoto-Honda R, Kaburagi Y, et al. Restored insulin-sensitivity in IRS-1-defcient mice treated by adenovirus-mediated gene therapy. J Clin Invest. 2000;105(10):1437-45.
31. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced IGF-1/insulin signaling and caloric restriction. Endocrinology. 2005;146(2):851-60. Epub 2004 Oct 21.
32. Kruis T, Klammt J, Galli-Tsinopoulou A, Wallborn T, Schlicke M, Muller E, et al. Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intraute-rine and postnatal growth retardation. J Clin Endocrinol Metab. 2010;95(3):1137-42.
33. Wallborn T, Wuller S, Klammt J, Kruis T, Kratzsch J, Schmidt G, et al. A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplas-mic reticulum and results in intrauterine and postnatal growth retardation. J Clin Endocrinol Metab. 2010;95(5):2316-24.
34. Fang P, Schwartz ID, Johnson BD, Derr MA, Roberts CT Jr, Hwa V, et al. Familial short stature caused by haploinsuffciency of the insulin-like growth factor i receptor due to nonsense-mediated messenger ribonucleic acid decay. J Clin Endocrinol Metab. 2009;94(5):1740-7.
35. Mohn A, Marcovecchio ML, de Giorgis T, Pfaeffe R, Chiarelli F, Kiess W. An insulin-like growth factor-I receptor defect associated with short stature and impaired carbohydrate homeostasis in an Italian pedigree. Horm Res Paediatr. 2011;76(2):136-43.
36. Inagaki K. A Familial insulin-like growth factor-I receptor mutant leads to short stature: clinical and biochemical characterization. J Clin Endocrinol Metab. 2007;92(4):1542-8.
37. Domene HM, Martinez AS, Frystyk J, Bengolea SV, Ropelato MG, Scaglia PA, et al. Normal growth spurt and fnal height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit defciency. Horm Res. 2007;67(5):243-9.
38. van Nieuwpoort IC, Drent ML. Cognition in the adult with childhood-onset GH defciency. Eur J Endocrinol. 2008;159(Suppl 1):S53-S7.
39. Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab. 2000;85(4):1407-11.
40. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia. 2004;47(6):1064-70.
41. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61-73.